Sepsis Mortality in CIITA Deficient Mice is Associated with Excessive Release of High-mobility Group Box 1 |
Kim, Ji-Young
(Department of Pathology, Hallym University College of Medicine)
Kim, Ju-Hyun (Department of Pathology, Hallym University College of Medicine) Seo, Jae-Nam (Department of Pathology, Hallym University College of Medicine) Oh, Kwon-Ik (Department of Pathology, Hallym University College of Medicine) |
1 | Annane D, Bellissant E, Cavaillon: Septic shock. Lancet 365;63-78, 2005 DOI ScienceOn |
2 | Yang H, Tracey KJ: High mobility group box 1. Crit Care Med 33;S472-S474, 2005 DOI PUBMED |
3 | Gourley T, Roys S, Lukacs NW, Kunkel SL, Flavell RA, Chang CH: A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity 10;377-386, 1999 DOI ScienceOn |
4 | Wong AW, Brickey WJ, Taxman DJ, van Deventer HW, Reed W, Gao JX, Zheng P, Liu Y, Li P, Blum JS, McKinnon KP, Ting JP: CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions. Nat Immunol 4;891-898, 2003 DOI ScienceOn |
5 | Yan JJ, Jung JS, Lee JE, Lee J, Huh SO, Kim HS, Jung KC, Cho JY, Nam JS, Suh HW, Kim YH, Song DK: Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med 10;161-167, 2004 DOI ScienceOn |
6 | Gourley TS, Chang CH: The class II transactivator prevents activation-induced cell death by inhibiting Fas ligand gene expression. J Immunol 166;2917-2921, 2001 DOI PUBMED |
7 | Fumeaux T, Pugin J: Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 166;1475-1482, 2002 DOI ScienceOn |
8 | dburger JM: Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 5;793-806, 2005 DOI ScienceOn |
9 | Ulloa L, Messmer D: High-mobility group box 1 (HMGB1) protein: Friend and foe. Cytokine Growth Factor Rev 17;189-201, 2006 DOI ScienceOn |
10 | Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ: HMG-1 as a late mediator of endotoxon lethality in mice. Science 285;248-251, 1999 DOI ScienceOn |
11 | Hotchkiss RS, Nicholson DW: Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 6;813-822, 2006 DOI ScienceOn |
12 | Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A, De Groote D, Abramowicz D, Velu T, Goldman M: Interleukin-10 controls interferon- and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 24;1167-1171, 1994 DOI ScienceOn |
13 | Zhu XS, Ting JP: A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promoters. Mol Cell Biol 21;7078-7088, 2001 DOI ScienceOn |
14 | Sessler CN, Shepherd W: New concepts in sepsis. Curr Opin Crit Care 8;465-472, 2002 DOI ScienceOn |
15 | Gourley TS, Patel DR, Nickerson K, Hong SC, Chang CH: Aberrant expression of Fas ligand in mice deficient for the MHC class II transactivator. J Immunol 168;4414-4419, 2002 DOI PUBMED |
16 | Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL: Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155;2222-2229, 1995 PUBMED |
17 | Buras JA, Holzmann B, Sitkovsky M: Animal mocel of sepsis: Setting the stage. Nat Rev Drug Discov 4;854-865, 2005 DOI ScienceOn |
18 | Reinhart K, Karzai W: Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned. Crit Care Med 29;S121-S125, 2001 DOI |
19 | Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348;1546-1554, 2003 DOI ScienceOn |
20 | Ting JP, Trowsdale J: Genetic expression of MHC class II expression. Cell 109;S21-S33, 2002 DOI ScienceOn |
21 | Pachot A, Monneret G, Brion A, Venet F, Bohe J, Bienvenu J, Mougin B, Lepape A: Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 33;31-38, 2005 DOI ScienceOn |
22 | Qin S, Wang H, Yuan R, Li H, Ochani M, Ochani K, Rosas-Ballina M, Czura CJ, Huston JM, Miller E, Lin X, Sherry B, Kumar A, Larosa G, Newman W, Tracey KJ, Yang H: Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 203;1637-1642, 2006 DOI ScienceOn |
23 | Le Tulzo Y, Pangault C, Amiot L, Guilloux V, Tribut O, Arvieux C, Camus C, Fauchet R, Thomas R, Drenou B: Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med 169;1144-1151, 2004 DOI ScienceOn |
24 | Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 5;331-342, 2005 DOI ScienceOn |
25 | Sewnath ME, Olszyna DP, Birjmohun R, ten Kate FJ, Gouma DJ, van Der Poll T: IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J immunol 166;6323-6331, 2001 DOI PUBMED |
26 | Buttice G, Miller J, Wang L, Smith SD: Interferon- induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells. Circ Res 98;472-479, 2006 DOI ScienceOn |